Through the analysis of a large number of clinical samples, it was discovered that TGF-β signaling is a primary reason for the exclusion of T-cells from the tumor core, which in turn directly leads to the ineffectiveness of PD-L1 inhibitors [183]. This evidence concerns the gene TGFB1 and neoplasm.